ABL Bio Market Cap

ABL Bio has a market cap or net worth of 4.77 trillion as of August 15, 2025. Its market cap has increased by 253.92% in one year.

Market Cap

4.77T

Enterprise Value

4.68T

Revenue

94.93B

Ranking

n/a

PE Ratio

n/a

Stock Price

87,400.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 4.77T, an increase of 683.73%. That is a compound annual growth rate of 36.24%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	4,769.86B	230.41%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	1,438.26B	31.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.52T
Celltrion	38.58T
ALTEOGEN	23.35T
Yuhan	8,561.74B
Peptron	8,235.61B
SK Biopharmaceuticals	7,878.31B
PharmaResearch	7,106.52B
LigaChem Biosciences	5,666.20B

Market Cap Rankings